This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
November 9–11, 2026
KoelnmesseCologne, Germany

Tina Soulis
CEO at Alithia Life Sciences Pty Ltd
Speaker

Profile

A/Prof Tina Soulis has over 30 years of working in the healthcare (pharmaceuticals and devices), biotechnology, academic research, clinical research and management sectors in senior roles including: CEO of a Contract Research Organization, Director of a successful ASX200 company, VP of Clinical Strategy and Development with an innovative biotechnology company and now, Founder and Director of her own full-service capability clinical CRO. A dynamic and strategic leader, Tina has an extensive network of stakeholders all over the world and experience in many therapeutic areas across all phases on development.

Tina holds academic appointments with the University of Melbourne.

Passionate about mentoring future industry leaders and advocating for the Australian R&D community, Tina serves on several therapeutic executive advisory boards, as Australian resident director to a portfolio of overseas entities and advisors many US-based biotechnology companies.

Recently, Tina launched Alithia Life Sciences, where her motivation and mission is to work with her clients to deliver efficient accomplishment of their project, add value to their programs and to ultimately enable improvement of human health and wellbeing.

Tina is one of the few Australian clinical development leaders who has successfully taken products from lab to regulatory approval.

Agenda Sessions

  • What Starts Down Under Doesn’t Stay Down Under: Australian Clinical Data as a Global Launchpad

    , 09:55